Type 1 IGF receptor in human breast diseases (original) (raw)

References

  1. Moses AC, Pilistine SJ: Insulin-like growth factors control of animal cell proliferation.In Boynton AL, Leffert HL (eds) Control of Animal Cell Proliferation, Vol I. Academic Press, New York, 1985, pp 91–120
    Google Scholar
  2. Rosenfeld RG, Hintz RL: Somatomedin receptors function and regulation.In Conn PM (ed) The Receptors, Vol 3. Academic Press, New York, 1988, pp 281–329
    Google Scholar
  3. Peyrat JP, Bonneterre J, Dusanter-Fourt I, Leroy-Martin B, Djiane J, Demaille A: Characterization of insulin-like growth factor 1 receptors (IGF1-R) in human breast cancer cell lines. Bull Cancer 76:311–319, 1989
    PubMed Google Scholar
  4. Pollak MN, Polychronakos C, Yousefi S, Richard M: Characterization of insulin-like growth factor I (IGF-I) receptors of human breast cancer cells. Biochem Biophys Res Commun 154:326–331, 1988
    PubMed Google Scholar
  5. De Leon DD, Bakker B, Wilson DM, Hintz RL, Rosenfeld RG: Demonstration of insulin-like growth factor (IGF-1 and -2) receptors and binding protein in human breast cancer cell lines. Biochem Biophys Res Commun 152:398–405, 1988
    PubMed Google Scholar
  6. Furlanetto RW, Di Carlo JN: Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture. Cancer Res 44:2122–2128, 1984
    PubMed Google Scholar
  7. Myal Y, Shiu RPC, Bhaumick B, Bala M: Receptor binding and growth promoting activity of insulin-like growth factor in human breast cancer cells (T47-D) in culture. Cancer Res 44:5486–5490, 1984
    PubMed Google Scholar
  8. Osborne CK, Coronado EB, Kitten LJ, Arteaga CL, Fuqua SAW, Marshall M, Li CH: Insulin-like growth factor-II (IGFII): a potential autocrine /paracrine growth factor for human breast cancer acting via the IGF1 receptor. Mol Endocrinol 3:1701–1709, 1989
    PubMed Google Scholar
  9. Stewart AJ, Johnson MD, May FEB, Westley BR: Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human brest cancer cells. J Biol Chem 265:21172–21178, 1990
    PubMed Google Scholar
  10. Freiss G, Rochefort H, Vignon F: Mechanism of 4-hydroxytamoxifen anti-growth factor activity in breast cancer cells: alterations of growth factor receptor binding sites and tyrosine kinase activity. Biochem Biophys Res Commun 173:919–926, 1990
    PubMed Google Scholar
  11. Mathieu M, Rochefort H, Barenton B, Prebois C, Vignon F: Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/ mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. Mol Endocrinology 4:1327–1335, 1990
    Google Scholar
  12. Kull FC, Jacobs S, Su Y-F, Svoboda ME, Van Wyck JJ, Cuatrecasas P: Monoclonal antibody to receptor for insulin and somatomedin-C. J Biol Chem 258:6561–6566, 1983
    PubMed Google Scholar
  13. Jacobs S, Cook S, Svoboda ME, Van Wyck JJ: Interaction of the monoclonal antibodies alpha-IR1 and alpha-IR3 with insulin and somatomedin-C receptors. Endocrinology 118:223–226, 1986
    PubMed Google Scholar
  14. Rohlik QT, Adams D, Kull FC, Jacobs S: An antibody to the receptor for IGF I inhibits the growth of MCF-7 cells in tissue culture. Biochem Biophys Res Commun 149:276–281, 1987
    PubMed Google Scholar
  15. Arteaga CL, Osborne CK: Growth inhibition of human breast cancer cells_in vitro_ with an antibody against the type I somatomedin receptor. Cancer Res 49:6237–6241, 1989
    PubMed Google Scholar
  16. Arteaga CL, Kitten LJ, Coronado EB, Jacobs S, Kull FC, Allred DC, Osborne CK: Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J Clin Invest 84:1418–1423, 1989
    PubMed Google Scholar
  17. Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N: Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 50:48–53, 1990
    PubMed Google Scholar
  18. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E, Jacobs S, Franke U, Ramachandran J, Fujita-Yamaguchi Y: Insulin-like growth factor 1 receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5:2503–2512, 1986
    PubMed Google Scholar
  19. Papa V, Hartmann KKP, Rosenthal SM, Maddux BA, Siiteri PK, Goldfine ID: Progestins induce down-regulation of insulin-like growth factor I (IGFI) receptors in human breast cancer cells: potential autocrine role of IGF-II. Mol Endocrinol 5:709–717, 1991
    PubMed Google Scholar
  20. Peyrat JP, Bonneterre J, Beuscart R, Djiane J, Demaille A: Insulin-like growth factor I receptor (IGF1-R) in human breast cancer. Relation to estradiol and progesterone receptors. Cancer Res 48:6429–6433, 1988
    PubMed Google Scholar
  21. Pekonen F, Partanen S, Mäkinen T, Rutanen EM: Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer. Cancer Res 48:1343–1347, 1988
    PubMed Google Scholar
  22. Peyrat J-Ph, Jammes H, Ban E, Haour F, Edery M, Djiane J, Bonneterre J: Insulin-like growth factor 1 receptors (IGF1-R) in human breast tumors: histo-autoradiographic analysis (HAA) and mRNA expression. Proc Amer Soc Cancer Res 31:49 (Abstr 292), 1990
    Google Scholar
  23. Bonneterre J, Peyrat JP, Beuscart R, Demaille A: Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer. Cancer Res 50:6931–6935, 1990
    PubMed Google Scholar
  24. Pollak MN, Perdue JF, Margolese RG, Baer K, Richard M: Presence of somatomedin receptors on primary human breast and colon carcinomas. Cancer Letters 38:223–230, 1987
    PubMed Google Scholar
  25. Foekens JA, Portengen H, Van Putten WLJ, Trapman AMAC, Reubi JC, Alexieva-Figusch J, Klijn JGM: Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer. Cancer Res 49:7002–7009, 1989
    PubMed Google Scholar
  26. Berns EMJJ, Klijn JGM, Van Stavaren IL, Portengen H, Foekens JA: Sporadic amplification of the insulin-like growth factor 1 receptor gene in human breast tumors. Cancer Res 52:1036–1039, 1992
    PubMed Google Scholar
  27. Peyrat JP, Bonneterre J, Laurent JC, Louchez MM, Amrani S, Leroy-Martin B, Vilain MO, Delobelle A, Demaille A: Presence and characterization of insulin-like growth factor 1 receptors in human benign breast disease. Eur J Cancer Clin Oncol 24:1425–1431, 1988
    PubMed Google Scholar
  28. Bonneterre J, Peyrat JP, Laurent JC, Jammes H, Hecquet B, Vilain MO, Demaille A: Prolactin receptors (PRL-R), insulin-like growth factor receptors (IGF1-R) and IGF1 plasma level in benign breast disease. Cancer Detec Prev, in press, 1992
  29. Haour F, Dussaillant M, Leblanc P, Rostene W: Mise en évidence et répartition topographique des récepteurs du LH-RH chez le rat mâle normal et castré au niveau du système nerveux central. C R Acad Sci Paris 305:41–42, 1987
    PubMed Google Scholar
  30. Peyrat JP, Bonneterre J, Vennin Ph, Louchez MM, Fournier C, Hecquet B, Lefebvre J, Demaille A: Insulin-like growth factor 1 (IGF1) plasma concentration in breast cancer (BC) patients. Proc Amer Soc Cancer Res:31:50 (Abstr 295), 1990
    Google Scholar
  31. Vennin Ph, Peyrat JP, Bonneterre J, Louchez MM, Harris AG, Demaille A: Effect of the long-acting somatostatin analogue SMS 201-995 (Sandostatin) in advanced breast cancer. Anticancer Res 9:153–156, 1989
    PubMed Google Scholar
  32. Bonneterre J, Mauriac L, Weber B, Roche H, Fargeot P, Tubiana-Hulin M, Sevin M, Chollet P, Cappelaere P: Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: results of a double blind multicentre clinical trial. Eur J Cancer Clin Oncol 24:1851–1853, 1988
    PubMed Google Scholar

Download references